Drugplain

Cotempla XR-ODT 25.9 mg/1

Methylphenidate · TABLET, ORALLY DISINTEGRATING · Neos Therapeutics Brands, LLC

No Recall HistoryCurrently in Shortage
Plain English

Cotempla Xr-Odt is a prescription medication containing methylphenidate, a central nervous system stimulant used to treat attention-deficit/hyperactivity disorder (ADHD). The orally disintegrating tablet form dissolves in your mouth and may be easier to take than traditional pills.

Key Facts

Brand Name
Cotempla XR-ODT
Generic Name
Methylphenidate
NDC Code (Product)
70165-300
Manufacturer
Neos Therapeutics Brands, LLC
Strength
25.9 mg/1
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Marketing Status
DEA Schedule
Schedule II (Controlled)
Application #
NDA205489
Drug Class
Central Nervous System Stimulant [EPC]
Marketing Start
06/20/2017

Recall History

No Recall History

Frequently Asked Questions

What is Cotempla XR-ODT used for?

Cotempla Xr-Odt is a prescription medication containing methylphenidate, a central nervous system stimulant used to treat attention-deficit/hyperactivity disorder (ADHD). The orally disintegrating tablet form dissolves in your mouth and may be easier to take than traditional pills.

Is Cotempla XR-ODT a controlled substance?

Yes, Cotempla XR-ODT is classified as CII under the DEA Controlled Substances Act.

What is the generic name for Cotempla XR-ODT?

The generic name for Cotempla XR-ODT is Methylphenidate. There are 12 other brand versions of Methylphenidate.

What is the NDC code for Cotempla XR-ODT 25.9 mg/1?

The NDC (National Drug Code) for Cotempla XR-ODT 25.9 mg/1 is 70165-300, listed by Neos Therapeutics Brands, LLC.